Goal

To bring together international groups of experts ranging from scientists to clinicians, all focused on understanding and improving outcome for patients with NPC.

Objectives

1. To share knowledge on Epstein-Barr virology, in relation to causation and progression of NPC
2. To understand the molecular pathogenesis of NPC, and how this information can help in developing biomarkers for NPC
3. To understand the range of therapeutic approaches on treating NPC
4. To understand the role of potential novel therapies which might improve outcome for patients with NPC
5. To identify the knowledge gaps and promote collaborative research on NPC

Target audience

Research Scientists, clinical researchers, ENT surgeons, Oncologists, Radiotherapists, Epidemiologists, Pathologists, Virologists, Immunologists, medical officers, all professionals and trainees who are interested in nasopharyngeal carcinoma.

Meeting topics

• Disease burden of NPC
• Genetic predisposition and environmental factors for the development of NPC
• Molecular pathogenesis and cellular biology of NPC, which include the contribution of Epstein-Barr Virus to the causation and progression of NPC
• Diagnosis and biomarkers for NPC
• Therapeutic approaches and potential novel therapies for NPC
• Identification of knowledge gaps in the clinic and scientific research and promotion of collaborative research